Back to search

Germany· DE-A57-5067421ad49e35bd

P-Tabletten Weiß 7 Mm Lichtenstein

A placebo product containing placebo, registered in Germany by Winthrop Arzneimittel Gmbh.

ATC V03AX10

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedP-Tabletten Weiß 7 Mm LichtensteinATCV03AX10REGISTER NO.DE-A57-5067421ad49e35…PACKS LISTED0CHECKEDSeptember 30, 2026

The record

At a glance

EMA Article 57 (European Union)
Active substance
Placebo
Manufacturer
Winthrop Arzneimittel Gmbh
Country
Germany (DE)
ATC code
V03AX10
ATC class
Placebo
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Placebo in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All placebo products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9fa37bd4-11b5-4a53-97f4-61eaf3ba6c82
GET /v1/drugs/9fa37bd4-11b5-4a53-97f4-61eaf3ba6c82?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Placebo",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about placebo.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.